Pharmaceutical and Life Sciences

Rx Marketplace Quarterly: Q4 2016 update

The PwC Rx Marketplace Quarterly features a wide range of financial reporting developments, accounting and tax developments, regulatory updates and general industry trends impacting the pharmaceutical and life sciences industry. In each issue we also discuss the most recent quarters' industry IPO's, venture capital funding and M&A activity.

"The U.S. presidential election tops the list of hot topics in the current period. In this edition, we reflect on the potential impacts of the election to the broader healthcare environment and income taxes which may be significant to companies in the sector."

Karen C. Young, US pharmaceuticals and life sciences assurance leader

Included in this edition of Rx Marketplace Quarterly:

  • We provide the most recent news related to the new revenue standard and considerations for companies related to assessing going concern.
  • A summary of the 2016 SEC comment letter trends as well as highlights from the AICPA Conference on Current SEC and PCAOB Developments.
  • A spotlight section on sustainability and other non-financial disclosures which are increasingly being requested by investors and other stakeholders of financial statements.


Contact us

Karen C. Young
US Pharmaceutical and life sciences Assurance Leader
Tel: +1 (973) 236 5648

Follow us